Webinar: What No-one tells you about clinical trials and why it matters for your care

Whether you’re living with follicular lymphoma, supporting someone who is, or simply want to learn more, this webinar recording offers an informative and supportive discussion with Beth Faiman, research nurse at the Cleveland Clinic Taussig Cancer Canter, and Dave Harrison, a patient living with follicular lymphoma who is currently taking part in a clinical trial. Together, they share expert insights with our chief medical officer Dr Mitchell Smith. These real-life experiences will help you better understand the role of clinical trials in developing new treatments and what taking part is really like. Learn more about our speakers on our website: https://www.theflf.org/upcoming-webin... Key topics include: What clinical trials are and how they work Why they’re vital for improving treatment options How participant safety is carefully managed What daily life in a trial can look like How to find trials relevant to you What questions to ask your healthcare team How to decide if taking part is right for you How to feel more confident in conversations with your care team More information: We have tried to keep conversation as jargon free as possible but if there are any terms you don't understand you may find it helpful to look at our glossary: https://www.theflf.org/your-support-h... You can register your interest in our webinars to be notified when you can register here: https://www.theflf.org/upcoming-webin... If you've found our videos helpful, please consider donating to the Follicular Lymphoma Foundation. Your support helps us accelerate research towards a cure for FL and improve the lives of those affected: https://www.theflf.org/donate/ [Disclaimer: This video is intended for educational and disease awareness purposes only and the information presented and discussed does not constitute medical advice. Please consult with your healthcare provider for medical advice.] Acknowledgement - This webinar series is supported by sponsorship from AstraZeneca, Genmab, AbbVie and Incyte. All of the above have had no influence on, control of, nor input into the development or performance of the webinar series.